{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:06:21Z","timestamp":1789398381390,"version":"build-2803163510"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02362-y","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T06:10:46Z","timestamp":1655532646000},"page":"1777-1781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Overview of use, efficacy, and safety of dupilumab in complex patients: a retrospective, case-series study from a large, urban academic center"],"prefix":"10.1007","volume":"315","author":[{"given":"Danitza","family":"Lukac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8490-0169","authenticated-orcid":false,"given":"Jean S.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"issue":"1","key":"2362_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/09546634.2019.1689227","volume":"32","author":"AJ Hendricks","year":"2021","unstructured":"Hendricks AJ, Yosipovitch G, Shi VY (2021) Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review. J Dermatol Treat 32(1):19\u201328. https:\/\/doi.org\/10.1080\/09546634.2019.1689227","journal-title":"J Dermatol Treat"},{"issue":"10","key":"2362_CR2","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1111\/jdv.17264","volume":"35","author":"N Siliquini","year":"2021","unstructured":"Siliquini N, Giura MT, Viola R et al (2021) Atopic dermatitis, dupilumab and cancers: a case series. J Eur Acad Dermatol Venereol 35(10):e651\u2013e652. https:\/\/doi.org\/10.1111\/jdv.17264","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2362_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/jdv.17094","volume":"35","author":"C Patruno","year":"2021","unstructured":"Patruno C, Napolitano M, Argenziano G et al (2021) Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol 35(4):958\u2013964. https:\/\/doi.org\/10.1111\/jdv.17094","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2362_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jdcr.2019.05.007","volume":"5","author":"K Ly","year":"2019","unstructured":"Ly K, Smith MP, Thibodeaux Q, Beck K, Bhutani T, Liao W (2019) Dupilumab in patients with chronic hepatitis B on concomitant entecavir. JAAD Case Rep 5(7):624\u2013626. https:\/\/doi.org\/10.1016\/j.jdcr.2019.05.007","journal-title":"JAAD Case Rep"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02362-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:04:12Z","timestamp":1689163452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02362-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":4,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02362-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"23 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DL and KP do not have any conflict of interest to report; JSM has an investigator-initiated dupilumab study that is funded by Regeneron Pharmaceuticals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was determined to be exempt by the Beth Israel Deaconess Medical Center Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB statement"}}]}}